NCT00871208View on ClinicalTrials.gov

Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Atopic Dermatitis
Interventions
DRUG

Altabax (R)

Retapamulin 1% ointment is to be applied to lesional atopic dermatitis twice-daily in addition to a topical corticosteroid (Locoid lipocream (R))

DRUG

Vehicle and Locoid lipocream (R)

The vehicle base of retapamulin ointment will be applied twice-daily to active lesions of atopic dermatitis in addition to locoid lipocream (R)

Trial Locations (3)

10003

Department of Dermatology, Beth Israel Medical Center, New York

10019

Department of Dermatology, Roosevelt Hospital, New York

10025

Department of Dermatology, St. Luke's-Roosevelt-Hospital Center, New York

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

St. Luke's-Roosevelt Hospital Center

OTHER